# US 2024/0002832 A1 · A method for isolating molecules and/or molecular complexes

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0002832 A1
- Document ID: US20240002832A1
- Status: Published application
- Kind: A1
- Application number: 18/254,446
- Filed: 2021-12-07
- Published: 2024-01-04
- Earliest claimed: 2020-12-07
- Assignees: Centre National De La Recherche Scientifique; Institut National Des Sciences Appliquees De Toulouse
- Applicants: Centre National De La Recherche Scientifique; Institut National Des Sciences Appliquees De Toulouse
- Inventors: Aline CERF; Christophe VIEU; Hélène CAYRON; Mouhanad BABI; Denis ESTRADE; Alexiane LARROCHE
- Web page: https://patentgrep.com/patent/US20240002832A1

## CPC

- C12N 15/1006: {by means of a solid support carrier, e.g. particles, polymers}
- G01N 33/5091: {for testing the pathological state of an organism}
- B01L 3/502761: {specially adapted for handling suspended solids or molecules independently from the bulk fluid flow, e.g. for trapping or sorting beads or physically stretching molecules}
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- G01N 33/5002: {Partitioning blood components}
- G01N 33/575: for cancer
- B01L 2200/0663: Stretching or orienting elongated molecules or particles
- G01N 33/491: {by separating the blood components (G01N15/05 takes precedence)}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

A method for isolating molecules and/or molecular complexes having a radius of gyration smaller or equal to 2 μm from a complex fluid, including the steps of: a) contacting a complex fluid with a structured capture array having topographical features, wherein the structured capture array is placed in an environment with surrounding humid air humidity of at least 40% based on the maximal moisture content, b) covering the deposited complex fluid with a covering element, wherein the surface tension of the complex fluid between the covering element and the structured capture array defines at least a front and a rear meniscus; and c) dragging either the covering element or the structured capture array in one direction at a speed of at most 2 mm·s−1 for displacing the complex fluid, resulting in that the molecules and/or the molecular complexes are trapped inside the cavities.

## Claims

### Claim at position 1

1-12. (canceled)

### Claim 13

A method for in vitro isolating molecules and/or molecular complexes having a radius of gyration smaller or equal to 2 μm from a complex fluid, said method comprising the following steps:
a) contacting a complex fluid with a structured capture array having topographical features in the form of a plurality of plane surfaces in-between cavities, wherein the structured capture array is surrounded by humid air and wherein said complex fluid is a non-Newtonian fluid,
b) covering the deposited complex fluid with a covering means such that the complex fluid is surrounded by a meniscus which comprises a rear meniscus and a front meniscus, wherein the surface tension of the complex fluid between the covering means and the structured capture array defines at least the front and the rear meniscus; and
c) dragging either the covering means or the structured capture array in one direction at a speed of at most 2 mm·s−1 for displacing the complex fluid, wherein the front and the rear menisci are displaced on and along the topographical features of said structured capture array toward said direction, wherein the front meniscus covers uncovered topographical features and the rear meniscus uncovers covered topographical features during displacement of the complex fluid, resulting in that:
the molecules and/or the molecular complexes are trapped inside the cavities, and possibly elongated on the plane surfaces toward the direction of the dragging, wherein the humid air has a humidity of at least 40% based on the air maximal humidity.

### Claim 14 (depends on 13)

The method for in vitro isolating molecules and/or molecular complexes according to claim 13, wherein the humidity in step c) is from 40 to 80% based on the maximal moisture content of the surrounding air.

### Claim 15 (depends on 13)

The method for in vitro isolating molecules and/or molecular complexes according to claim 13, wherein the molecules are biological molecules, in particular the biological molecules are nucleic acid molecules, particularly the nucleic acid molecules are selected from the group comprising viral nucleic acid molecules, chromatin, circulating free DNA, RNA, linear DNA, linear RNA, circular DNA, circular RNA, single-stranded DNA, double-stranded DNA, and tumoral DNA.

### Claim 16 (depends on 13)

The method for in vitro isolating molecules and/or molecular complexes according to claim 13, wherein the molecular complexes are biological complexes, in particular the biological molecular complexes are selected in the group comprising vacuoles, lysosomes, transport vesicles, secretory vesicles, liposomes, ectosomes, microvesicles, virus, part of virus, exosomes and macro complex.

### Claim 17 (depends on 13)

The method for in vitro isolating molecules and/or molecular complexes according to claim 13, wherein the complex fluid is a biological fluid of an individual, in particular said biological fluid is selected in the group consisting of cerebrospinal fluid, pleural effusion, saliva, urine, blood, plasma and serum, especially the biological fluid is blood.

### Claim 18 (depends on 13)

The method for in vitro isolating molecules and/or molecular complexes according to claim 13, wherein before or at step a), the complex fluid is blended with a surfactant, in particular a non-ionic surfactant.

### Claim 19 (depends on 18)

The method for in vitro isolating molecules and/or molecular complexes according to claim 18, wherein before or at step a), the complex fluid is blended with 0.1 to % v/v Triton X100, particularly 0.3% v/v TritonX100.

### Claim 20 (depends on 13)

The method for in vitro isolating molecules and/or molecular complexes according to claim 13, wherein molecules and/or molecular complexes of different radius of gyration have to be isolated, and wherein step c) is carried out at least two times at different speeds for each radius of gyration.

### Claim 21 (depends on 13)

The method for in vitro isolating molecules and/or molecular complexes according to claim 13, wherein molecules and/or molecular complexes of different radius of gyration have to be isolated, wherein the structured capture array comprises at least a first and a second portions of topographical features wherein the first portion has larger cavities than the second one, such that step c) results in the spatial separation onto the structured capture array of the isolated molecules and/or molecular complexes of different radii of gyration.

### Claim 22 (depends on 13)

The method for in vitro isolating molecules and/or molecular complexes according to claim 13, wherein the cavities of the structured capture array are functionalised with a linking element configured for trapping the molecules and/or complexes.

### Claim 23 (depends on 13)

The method for in vitro isolating molecules and/or molecular complexes according to claim 13, wherein the process of the invention comprises a further step d):
d) contacting the surface of the structured capture array with a printing surface for transferring the trapped molecules and/or molecular complexes from the surface of the structured capture array to the printing surface.

### Claim 24

A structured capture array for in vitro isolating molecules and/or molecular complexes having a radius of gyration smaller than 2 μm from a complex fluid comprising numerous components, wherein the structured capture array having topographical features in the form of a plurality of plane surfaces in-between cavities.
